Discontinued — last reported Q2 '23
Business Segments · D&A
Medical — D&A
Cardinal Health Medical — D&A remained flat by 0.0% to $53.25M in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $54.00M to $53.25M. Over 2 years (FY 2021 to FY 2023), Medical — D&A shows relatively stable performance with a -2.9% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ3 2018
Last reportedQ2 2023
Rolls up toD&A
How to read this metric
High levels relative to revenue may indicate a capital-intensive business model, while sudden changes can reflect shifts in asset base or accounting estimates.
Detailed definition
This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within t...
Peer comparison
Varies significantly based on the asset-heaviness of the specific medical business model compared to peers.
Metric ID:
cah_segment_medical_depreciation_and_amortizationHistorical Data
3 years
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $226.00M | $216.00M | $213.00M |
| YoY Change | — | -4.4% | -1.4% |
Range$213.00M – $226.00M
CAGR-2.9%
Avg YoY Growth-2.9%
Median YoY Growth-2.9%
Current Streak2+ years decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's medical — d&a?
- Cardinal Health (CAH) reported medical — d&a of $53.25M in Q2 2023.
- How has Cardinal Health's medical — d&a changed year-over-year?
- Cardinal Health's medical — d&a decreased by 1.4% year-over-year, from $54.00M to $53.25M.
- What is the long-term trend for Cardinal Health's medical — d&a?
- Over 2 years (2021 to 2023), Cardinal Health's medical — d&a has grown at a -2.9% compound annual growth rate (CAGR), from $226.00M to $213.00M.
- What does medical — d&a mean?
- The non-cash expense representing the gradual loss of value of the segment's physical and intangible assets over time.